14/05/2026
PCOS is no longer being viewed as just an ovarian disorder.
The shift toward PMOS - Polyendocrine Metabolic Ovarian Syndrome reflects what endocrine research has been showing for years:
this is a full-body metabolic and hormonal condition, not simply a “cyst” problem.
Because in most women, the dysfunction starts far beyond the ovaries:
• Insulin resistance
• Hyperandrogenism
• Neuroendocrine disruption
• Chronic inflammation
• Metabolic dysfunction
That’s exactly why many women with “normal scans” still experience:
→ Irregular periods
→ Acne and facial hair
→ Hair thinning
→ Belly fat and sugar cravings
→ Fatigue and mood changes
→ Fatty liver and abnormal lipids
Studies estimate insulin resistance in up to 70–85% of PCOS cases, including lean women.
The term PMOS matters because the old name narrowed the disease to the ovaries, while the actual condition affects the entire endocrine network.
